Evaxion A (EVAX) Research & Development (2020 - 2026)

Evaxion A has reported Research & Development for 7 years, with the latest figure at -$2.3 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 6.59% year-over-year to -$2.3 million; the trailing twelve-month figure through Mar 2026 stood at -$10.1 million (down 3.45% YoY), and the FY2025 full-year result was -$10.0 million, up 4.61% from the prior year.
• Research & Development for Q1 2026 stood at -$2.3 million, up from -$2.6 million in the prior quarter.
• The five-year high for Research & Development was $4.8 million in Q1 2022, with the low at -$4.1 million in Q4 2022.
• Historically, Research & Development has averaged -$1.5 million across 5 years, with a median of -$2.6 million in 2025.
• The largest YoY upside for Research & Development was 43.58% in 2023 against a maximum downside of 180.18% in 2023.
• Evaxion A's Research & Development stood at -$4.1 million in 2022, then soared by 43.58% to -$2.3 million in 2023, then increased by 1.87% to -$2.3 million in 2024, then slipped by 13.48% to -$2.6 million in 2025, then grew by 10.2% to -$2.3 million in 2026.
• The last three Research & Development figures came in at -$2.3 million (Q1 2026), -$2.6 million (Q4 2025), and -$3.1 million (Q3 2025), per Business Quant data.